Skip to main content
. 2021 Nov 13;31(1):1–25. doi: 10.1007/s00044-021-02819-1

Table 2.

VEGFR-2 and FGFR-1 biochemical and cellular potencies of compounds 6, 7, and 8

Entry IC50 (nM)
Kinase inhibition Growth inhibition of HUVECs
VEGFR-2 FGFR-1 VEGF FGF
6 57 100 17 21
7 16 16 2.1 4.6
8 53 220 27 130